Showing results (11-20 of 678) with videos related to
Sort By:
Pageof 68
Journal of Medicinal Chemistry|December 1, 1988
Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmineQ S Yu, J R Atack, S I Rapoport, et al.FEBS Letters|July 4, 1988
Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesteraseQ S Yu, J R Atack, S I Rapoport, et al.Brain Research|July 2, 1993
Regional specificity of membrane instability in Alzheimer's disease brainL Ginsberg, J R Atack, S I Rapoport, et al.Molecular and Chemical Neuropathology|May 1, 1993
Evidence for a membrane lipid defect in Alzheimer diseaseL Ginsberg, J R Atack, S I Rapoport, et al.Journal of Mental Deficiency Research|June 1, 1990
Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilizationB Horwitz, M B Schapiro, C L Grady, et al.Experimental Gerontology|January 1, 1990
pp60c-src kinase expression in brain of adult rats in relation to ageM F Matocha, S W Fitzpatrick, J R Atack, et al.Biochemical and Biophysical Research Communications|August 31, 1987
Selective elevation of c-myc transcript levels in the liver of the aging Fischer-344 ratM F Matocha, J W Cosgrove, J R Atack, et al.The Journal of Clinical Investigation|February 1, 1995
Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluidH U Shetty, M B Schapiro, H W Holloway, et al.Brain Research|June 6, 2000
Phospholipid composition and levels are altered in Down syndrome brainE J Murphy, M B Schapiro, S I Rapoport, et al.Journal of Clinical and Experimental Neuropsychology|July 1, 1992
Individual trajectories of cognitive decline in patients with dementia of the Alzheimer typeJ V Haxby, K Raffaele, J Gillette, et al.Pageof 68